These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 9844503

  • 1. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS.
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [Abstract] [Full Text] [Related]

  • 2. Management of obesity in non- insulin- dependent diabetes mellitus.
    Cheah JS.
    Asia Pac J Clin Nutr; 1998 Dec; 7(3/4):282-6. PubMed ID: 24393684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G.
    Diabete Metab; 1993 Dec; 19(1):30-5. PubMed ID: 8504882
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment modalities of obesity: what fits whom?
    Hainer V, Toplak H, Mitrakou A.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [Abstract] [Full Text] [Related]

  • 9. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S, Richelsen B.
    Ugeskr Laeger; 2006 Jan 09; 168(2):175-9. PubMed ID: 16403345
    [Abstract] [Full Text] [Related]

  • 10. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus.
    Wing RR.
    J Am Diet Assoc; 1995 May 09; 95(5):569-72; quiz 573-4. PubMed ID: 7722192
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.
    J Am Acad Nurse Pract; 2007 Jul 09; 19(7):368-77. PubMed ID: 17680902
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.
    Metabolism; 2001 Dec 09; 50(12):1457-61. PubMed ID: 11735093
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct 09; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 20. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P.
    Metabolism; 2001 Jul 09; 50(7):856-61. PubMed ID: 11436194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.